Diarylpentanoid, a curcumin analog, inhibits malignant meningioma growth in both in vitro and in vivo models

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

346

Figures (1-7)

167

Tables (1-2)

138

Sum=668

Publishing Process of This Article

Item

Count

Browse

Download

Sum=40

Jun 20, 2025 (publication date) through Jun 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Exp Med. Jun 20, 2025; 15(2): 102897
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.102897

Table 2 In vivo distribution of GO-Y030

Times after administration (hour)	1	3	6
Blood concentration (ng/mL)	18.0	46.7	58.2
Brain distribution (pg/mg tissue)	0	26.8	23.1

Citation: Terasawa A, Shimazu K, Nanjo H, Miura M, Shibata H. Diarylpentanoid, a curcumin analog, inhibits malignant meningioma growth in both in vitro and in vivo models. World J Exp Med 2025; 15(2): 102897
URL: https://www.wjgnet.com/2220-315x/full/v15/i2/102897.htm
DOI: https://dx.doi.org/10.5493/wjem.v15.i2.102897